Overview
Health care cost to society has risen to levels which are no longer sustainable.
This fund invests globally in innovative companies which are driving a revolution in the health care sector through the application of technology.
The investment universe comprises three segments: Research & Development, Treatments and Efficiency. The fund invests in “pure-play” digital health companies, which are typically small to mid-sized.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
The exchange rate risk between USD and EUR is not hedged.
Benefits
Offers diversified exposure to the digital health universe, which is one of the fastest growing segments in the health care industry.
The investment objective is long-term capital appreciation from actively managed exposure to this secular growth theme.
Risks
Features
| Product category |
麻豆社 Thematic Funds
|
| Product domicile |
Luxembourg
|
| Portfolio management |
麻豆社 Asset Management (Americas) LLC, New York
|
| Fund management |
麻豆社 Asset Management (Europe) S.A., Luxembourg
|
| Custodian bank |
麻豆社 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
麻豆社 AG, Stockholm
|
| Day of inception |
September 10, 2020
|
| Currency of account |
EUR
|
| Close of financial year |
May 31
|
| SFDR Classification |
Art.8
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
1.00% p.a.
|
| Management fee |
0.73% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI AC World (NR) in EUR
|
| ISIN |
LU2228203910
|
| Bloomberg Ticker |
CRDHEUE LX
|
| Reuters Id |
56929758X.CHE
|
Performance and Prices
Percentage growth
as of May 27, 2026| EUR(%) | |
| YTD | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | 2.12 |
| 2Y | |
| 3Y | -13.34 |
| 5Y | -39.57 |
| ø p.a.5Y | -9.58 |
Current data
| Net asset value | 27.05.2026 | EUR 75.48 |
| High - last 12 months | 28.11.2025 | EUR 87.11 |
| Low - last 12 months | 18.05.2026 | EUR 71.70 |
| Assets of the unit class in mn | 27.05.2026 | EUR 0.96 |
| Total product assets in mn | 27.05.2026 | EUR 388.63 |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| Intuitive Surgical Inc | 3.45 |
| IRhythm Holdings Inc | 3.24 |
| Guardant Health Inc | 3.22 |
| Medline Inc | 3.09 |
| Alcon AG | 3.03 |
| Arrowhead Pharmaceuticals Inc | 2.91 |
| Koninklijke Philips NV | 2.82 |
| Ionis Pharmaceuticals Inc | 2.68 |
| Chugai Pharmaceutical Co Ltd | 2.57 |
| Natera Inc | 2.54 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|
| Prospectus |
|
|
| Country supplement |
|
|
| Key Information Document |
|
|
| Past performance |
|
|
| Previous performance scenario |
|
|
| Statutes / Management regulations |
|
|
Document type
|
Document Language
|
| Annual report |
|
| Semi-annual report |
|